TURTLE CAMERON (Chief Business Officer) sold 3.4% of their position (2.50K shares) of EIDOS THERAPEUTICS, INC. on the open market
Open‑market sale worth $117.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/11/2020ACC: 0000899243-20-024894
Officer· Chief Business Officer
Since Nov 2018
-2.50K
Net shares
Net seller
$117.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.50K acquired · 5K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.50K
Price / share
$17.00
Trade value
$42.50K
% of position
3.5%
9/10/2020
70.53K→73.03K
Common Stock
Direct
Shares
−2.50K
Price / share
$47.00
Trade value
$117.50K
% of position
3.4%
9/10/2020
73.03K→70.53K
Total
Net shares
+0.00
Net value
-$75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/10/2020 | M · Option Exercise | +2.50K | $17.00 | $42.50K | 3.5% | 70.53K | 73.03K |
| Common Stock Direct | 9/10/2020 | S · Sale | −2.50K | $47.00 | $117.50K | 3.4% | 73.03K | 70.53K |
| Total | +0.00 | -$75K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
2.50K shares
Shares
−2.50K
Strike price
17.00
Held after
16.42K
Exercisable
—
9/10/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock2.50K shares | 9/10/2020 | M · Option Exercise | −2.50K | 17.00 | — | 16.42K |